Invasive disease by Streptococcus pneumoniae: a case report and a discussion about the immunization rates in older adults in Brazil

Authors

  • Guilherme Goulart Cabral-Oliveira Departamento de Microbiologia, Imunologia e Parasitologia; Faculdade de Ciências Médicas; Universidade do Estado do Rio de Janeiro (UERJ). https://orcid.org/0000-0001-9762-4669
  • Isabelle Christine de M. Motta Escola de Medicina e Cirurgia; Universidade do Estado do Rio de Janeiro (UNIRIO).Departamento de Doenças Infecciosas e Parasitárias; Hospital Naval Marcilio Dias; Marinha do Brasil. https://orcid.org/0000-0002-4418-4900
  • Paula Marcele A. Pereira-Ribeiro Departamento de Microbiologia, Imunologia e Parasitologia; Faculdade de Ciências Médicas; Universidade do Estado do Rio de Janeiro (UERJ). https://orcid.org/0000-0002-4864-9533
  • Paulo Vieira Damasco Departamento de Doenças Infecciosas e Parasitárias; Hospital Universitário Pedro Ernesto; Universidade do Estado do Rio de Janeiro (UERJ). Departamento de Doenças Infecciosas e Parasitárias; Hospital Universitário Gaffrée e Guinle; Universidade Federal do Estado do Rio de Janeiro (UNIRIO). https://orcid.org/0000-0001-5025-4007
  • Ana Luiza Mattos-Guaraldi Departamento de Microbiologia, Imunologia e Parasitologia; Faculdade de Ciências Médicas; Universidade do Estado do Rio de Janeiro (UERJ). https://orcid.org/0000-0003-2522-0416

DOI:

https://doi.org/10.12957/bjhbs.2023.77287

Keywords:

Streptococcus pneumoniae, Invasive disease, Vaccine, Pneumococcal vaccine.

Abstract

Invasive disease by Streptococcus pneumoniae has a high mortality rate, principally in old adults and children. This paper presents the progression and prognostic of a case of invasive pneumococcal disease in an elderly woman by vaccinal serotype and promotes a discussion about the monitorization of the vaccinal pneumococcal rate in an old adult population in Brazil.

Downloads

Download data is not yet available.

References

Marquart ME. Pathogenicity and virulence of Streptococcus pneumoniae: cutting to the chase on proteases. Virulence. 2021;12(1):766-87.

de Egea V; Muñoz P; Valerio M; de AlarcónA; Lepe JA; Miró JM; Fariñas MC. Characteristics and outcome of Streptococcus pneumoniae endocarditis in the XXI century: a systematic review of 111 cases (2000–2013). Medicine (Baltimore). 2015;94(39):e1562.

Domingues K, Marta L, Monteiro I, Leal M. Native aortic valve pneumococcal endocarditis-fulminant presentation. Rev Bras Ter Inten. 2016;28(1):83-6.

Brandileone MCC, Almeida SCG, Minamisava R, Andrade AL. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil. Vaccine, 2018;36(19):2559–66.

Rakočević R, Shapouran S Pergament KM. Austrian Syndrome - A Devastating Osler's Triad: Case Report and Literature Review. Cureus. 2019;11(4):e4486.

Daniels CC, Rogers PD, Shelton CM. A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens. J Pediatr Pharmacol Ther. 2016;21(1):27‐35.

Moreira M, Cintra O, Harriague J, Hausdorff WP, Hoet B. Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national immunization program. Vaccine. 2016;34(25):2766-78.

dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yoshioka CRM, Gilio AE, Martinez MB. Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation. Vaccine. 2013;31(51):6150-54.

Neves FPG, Cardoso NT, Cardoso CAA, Teixeira LM, Riley LW. Direct effect of the 13-valent pneumococcal conjugate vaccine use of pneumococcal colonization among children in Brazil. Vaccine. 2019;37(36):5265-69.

Pai R, Gertz RE, Beal B. Sequential multiplex PCR approach for determining capsular serotype of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44(1):124-31.

Aronin SI, Mukherjee SK, West JC, Cooney EL. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis. 1998;26(1): 165-171.

Centers for Disease Control and Prevention (CDC). Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013;62(16):308–11.

The 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3036‐37.

Ministério da Saúde [internet homepage]. Instrução normativa referente ao calendário nacional de vacinação - 2022. [accessed in January 30 of 2023]. URL: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/c/calendario-nacional-de-vacinacao/calendario-vacinal-2022/anexo-normativa-do-calendario-de-vacinacao-atualizado_-final-20-09-2022.pdf. (In Portuguese).

Nishikawa AM, Sartori AMC, Mainardi GM, Freitas AC, Itria A, Novaes HMD, et al. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older. Vaccine. 2018;36(19):2510-22.

Downloads

Published

2023-12-20

How to Cite

1.
Cabral-Oliveira GG, Motta IC de M, Pereira-Ribeiro PMA, Damasco PV, Mattos-Guaraldi AL. Invasive disease by Streptococcus pneumoniae: a case report and a discussion about the immunization rates in older adults in Brazil. BJHBS [Internet]. 2023 Dec. 20 [cited 2025 May 2];22(2):126-9. Available from: https://www.e-publicacoes.uerj.br/bjhbs/article/view/77287

Issue

Vol. 22 No. 2 (2023)

Section

Clinical Cases

License

Copyright (c) 2023 Brazilian Journal of Health and Biomedical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

After the final approval, authors must send the copyright transfer agreement signed by the first author representing each additional author. In this agreement must be stated any conflicts of interest.

Brazilian Journal of Health and Biomedical Sciences de http://bjhbs.hupe.uerj.br/ is licensed under a License Creative Commons - Attribution-NonCommercial 4.0 International.   Licença Creative Commons